The effects of TGF-β type I receptor inhibitor on scar hyperplasia in vivo
碩士 === 國防醫學院 === 生物及解剖學研究所 === 105 === Skin is the largest organ of the human body, can form a protective barrier, and avoid to exogenous pathogens and injuries. When the maturation/remodeling phase of wound healing process is interfered, it may result in excessive accumulation of ECM, named scar hy...
Main Authors: | LIN, CHIEN-WEN, 林建文 |
---|---|
Other Authors: | WANG, YI-WEN |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/25234121090298416698 |
Similar Items
-
Pentabromopseudilin: a myosin V inhibitor suppresses TGF-β activity by recruiting the type II TGF-β receptor to lysosomal degradation
by: Wang Shih-Wei, et al.
Published: (2018-01-01) -
Effect of P144® (Anti-TGF-β) in an "In Vivo" Human Hypertrophic Scar Model in Nude Mice.
by: Shan Shan Qiu, et al.
Published: (2015-01-01) -
Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor
by: Dwi U Kemaladewi, et al.
Published: (2014-01-01) -
Recombinant TGF-β type I and Type II receptor domains
by: Tang Bolton, Lina Wai Yue
Published: (1999) -
Synthesis and Evaluation of 3-Substituted-4-(quinoxalin-6-yl) Pyrazoles as TGF-β Type I Receptor Kinase Inhibitors
by: Li-Min Zhao, et al.
Published: (2018-12-01)